Menu

Filtros : "Current Pharmaceutical Design" "2015" Limpar

Filtros

Refine with date range

  • 1

1 - 6 (6 records)

  • Artigo de periodico

    Antisense therapy for cardiovascular diseases (2015)

    Ian Phillips, M; Costales, Jessica; J. Lee, Robert; Oliveira, E. M.; B. Burns, Andrew

    Source: Current Pharmaceutical Design. Unidade: EEFE

    Subjects: DOENÇAS CARDIOVASCULARES, SÍNDROME X METABÓLICA, HIPERTENSÃO, HIPERLIPIDEMIA, EXONS, RNA MENSAGEIRO, OLIGONUCLEOTÍDEOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      IAN PHILLIPS, M et al. Antisense therapy for cardiovascular diseases. Current Pharmaceutical Design, v. 21, n. 30, p. 4417-4426, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612821666150803150402. Acesso em: 16 nov. 2025.

    • APA

      Ian Phillips, M., Costales, J., J. Lee, R., Oliveira, E. M., & B. Burns, A. (2015). Antisense therapy for cardiovascular diseases. Current Pharmaceutical Design, 21( 30), 4417-4426. doi:10.2174/1381612821666150803150402

    • NLM

      Ian Phillips M, Costales J, J. Lee R, Oliveira EM, B. Burns A. Antisense therapy for cardiovascular diseases [Internet]. Current Pharmaceutical Design. 2015 ; 21( 30): 4417-4426.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612821666150803150402

    • Vancouver

      Ian Phillips M, Costales J, J. Lee R, Oliveira EM, B. Burns A. Antisense therapy for cardiovascular diseases [Internet]. Current Pharmaceutical Design. 2015 ; 21( 30): 4417-4426.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612821666150803150402

  • Artigo de periodico

    Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease (2015)

    Maranhão, Raul Cavalcante ; Leite, Antonio Carlos de Arruda

    Source: Current Pharmaceutical Design. Unidade: FCF

    Subjects: INFLAMAÇÃO, ARTERIOSCLEROSE, DOENÇAS CARDIOVASCULARES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MARANHÃO, Raul Cavalcante e LEITE, Antonio Carlos de Arruda. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Current Pharmaceutical Design, v. 21, n. 9, p. 1196-1204, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612820666141013150714. Acesso em: 16 nov. 2025.

    • APA

      Maranhão, R. C., & Leite, A. C. de A. (2015). Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Current Pharmaceutical Design, 21( 9), 1196-1204. doi:10.2174/1381612820666141013150714

    • NLM

      Maranhão RC, Leite AC de A. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease [Internet]. Current Pharmaceutical Design. 2015 ; 21( 9): 1196-1204.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612820666141013150714

    • Vancouver

      Maranhão RC, Leite AC de A. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease [Internet]. Current Pharmaceutical Design. 2015 ; 21( 9): 1196-1204.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612820666141013150714

  • Artigo de periodico

    Recent advances of radionuclide-based molecular imaging of atherosclerosis (2015)

    Kazuma, Soraya Megumi; Sultan, Deborah; Zhao, Yongfeng; Detering, Lisa; You, Meng; Luehmann, Hannah P; Abdalla, Dulcinéia Saes Parra ; Liu, Yongjian

    Source: Current Pharmaceutical Design. Unidade: FCF

    Subjects: ARTERIOSCLEROSE, NANOPARTÍCULAS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      KAZUMA, Soraya Megumi et al. Recent advances of radionuclide-based molecular imaging of atherosclerosis. Current Pharmaceutical Design, v. 21, n. 36, p. 5267-5276, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612821666150915104529. Acesso em: 16 nov. 2025.

    • APA

      Kazuma, S. M., Sultan, D., Zhao, Y., Detering, L., You, M., Luehmann, H. P., et al. (2015). Recent advances of radionuclide-based molecular imaging of atherosclerosis. Current Pharmaceutical Design, 21( 36), 5267-5276. doi:10.2174/1381612821666150915104529

    • NLM

      Kazuma SM, Sultan D, Zhao Y, Detering L, You M, Luehmann HP, Abdalla DSP, Liu Y. Recent advances of radionuclide-based molecular imaging of atherosclerosis [Internet]. Current Pharmaceutical Design. 2015 ; 21( 36): 5267-5276.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612821666150915104529

    • Vancouver

      Kazuma SM, Sultan D, Zhao Y, Detering L, You M, Luehmann HP, Abdalla DSP, Liu Y. Recent advances of radionuclide-based molecular imaging of atherosclerosis [Internet]. Current Pharmaceutical Design. 2015 ; 21( 36): 5267-5276.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612821666150915104529

  • Artigo de periodico

    Protein disulfide isomerase and Nox: new partners in redox signaling (2015)

    Trevelin, Silvia Cellone; Lopes, Lucia Rossetti

    Source: Current Pharmaceutical Design. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      TREVELIN, Silvia Cellone e LOPES, Lucia Rossetti. Protein disulfide isomerase and Nox: new partners in redox signaling. Current Pharmaceutical Design, v. 21, n. 41, p. 5951-5963, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612821666151029112523. Acesso em: 16 nov. 2025.

    • APA

      Trevelin, S. C., & Lopes, L. R. (2015). Protein disulfide isomerase and Nox: new partners in redox signaling. Current Pharmaceutical Design, 21( 41), 5951-5963. doi:10.2174/1381612821666151029112523

    • NLM

      Trevelin SC, Lopes LR. Protein disulfide isomerase and Nox: new partners in redox signaling [Internet]. Current Pharmaceutical Design. 2015 ; 21( 41): 5951-5963.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612821666151029112523

    • Vancouver

      Trevelin SC, Lopes LR. Protein disulfide isomerase and Nox: new partners in redox signaling [Internet]. Current Pharmaceutical Design. 2015 ; 21( 41): 5951-5963.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612821666151029112523

  • Artigo de periodico

    An apple plus a Brazil nut a day keeps the doctors away: antioxidant capacity of foods and their health (2015)

    Ferrari, Carlos Kusano Bucalen; Percário, Sandro; Silva, José Carlos Costa Baptista; Torres, Elizabeth Aparecida Ferraz da Silva

    Source: Current Pharmaceutical Design. Unidade: FSP

    Subjects: DOENÇAS CARDIOVASCULARES, TRANSTORNOS CEREBROVASCULARES, SUPLEMENTOS DIETÉTICOS, NEOPLASIAS, FITOTERAPIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FERRARI, Carlos Kusano Bucalen et al. An apple plus a Brazil nut a day keeps the doctors away: antioxidant capacity of foods and their health. Current Pharmaceutical Design, v. 22, n. 2, p. 189-195, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612822666151117122715. Acesso em: 16 nov. 2025.

    • APA

      Ferrari, C. K. B., Percário, S., Silva, J. C. C. B., & Torres, E. A. F. da S. (2015). An apple plus a Brazil nut a day keeps the doctors away: antioxidant capacity of foods and their health. Current Pharmaceutical Design, 22( 2), 189-195. doi:10.2174/1381612822666151117122715

    • NLM

      Ferrari CKB, Percário S, Silva JCCB, Torres EAF da S. An apple plus a Brazil nut a day keeps the doctors away: antioxidant capacity of foods and their health [Internet]. Current Pharmaceutical Design. 2015 ; 22( 2): 189-195.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612822666151117122715

    • Vancouver

      Ferrari CKB, Percário S, Silva JCCB, Torres EAF da S. An apple plus a Brazil nut a day keeps the doctors away: antioxidant capacity of foods and their health [Internet]. Current Pharmaceutical Design. 2015 ; 22( 2): 189-195.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612822666151117122715

  • Artigo de periodico

    Potential of peptide-based enhancers for transdermal delivery (2015)

    Lopes, Luciana Biagini ; Carvalho, Vanessa Freitas Mendonça de; Lemos, Débora P. de

    Source: Current Pharmaceutical Design. Unidade: ICB

    Subjects: FARMACOLOGIA, PEPTIDEOS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      LOPES, Luciana Biagini e CARVALHO, Vanessa Freitas Mendonça de e LEMOS, Débora P. de. Potential of peptide-based enhancers for transdermal delivery. Current Pharmaceutical Design, v. 21, n. 20, p. 2814-2822, 2015Tradução . . Disponível em: https://doi.org/10.2174/1381612821666150428143243. Acesso em: 16 nov. 2025.

    • APA

      Lopes, L. B., Carvalho, V. F. M. de, & Lemos, D. P. de. (2015). Potential of peptide-based enhancers for transdermal delivery. Current Pharmaceutical Design, 21( 20), 2814-2822. doi:10.2174/1381612821666150428143243

    • NLM

      Lopes LB, Carvalho VFM de, Lemos DP de. Potential of peptide-based enhancers for transdermal delivery [Internet]. Current Pharmaceutical Design. 2015 ; 21( 20): 2814-2822.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612821666150428143243

    • Vancouver

      Lopes LB, Carvalho VFM de, Lemos DP de. Potential of peptide-based enhancers for transdermal delivery [Internet]. Current Pharmaceutical Design. 2015 ; 21( 20): 2814-2822.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612821666150428143243
  • 1

1 - 6 (6 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025